| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | ||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 456,2 k € | +35.2% | 337,5 k € | -9.8% | 374,1 k € | +57.8% | 237,0 k € | +66.7% | 142,2 k € | -51.5% | 293,1 k € | +13.1% | 259,1 k € | +29.1% | 200,6 k € | -43.9% | 357,9 k € | +9.0% | 328,3 k € | +8.0% | 304,0 k € | +29.1% | 235,4 k € | +49.4% | 157,6 k € | -3.0% | 162,4 k € | +8.1% | 150,3 k € | -45.7% | 276,7 k € | -5.4% | 292,6 k € | |
| EBITDA | 454,7 k € | +35.5% | 335,6 k € | -9.4% | 370,7 k € | +59.4% | 232,6 k € | +68.7% | 137,8 k € | -52.2% | 288,4 k € | +13.1% | 255,0 k € | +30.8% | 195,0 k € | -44.7% | 352,5 k € | +8.8% | 323,9 k € | +7.9% | 300,1 k € | +32.3% | 226,8 k € | +47.3% | 154,0 k € | -3.2% | 159,0 k € | +6.3% | 149,6 k € | -45.8% | 276,0 k € | -5.5% | 291,9 k € | |
| Operating profit | 444,7 k € | +36.5% | 325,7 k € | -9.0% | 358,0 k € | +64.6% | 217,5 k € | +77.0% | 122,8 k € | -54.5% | 270,2 k € | +19.6% | 225,9 k € | +34.7% | 167,7 k € | -46.2% | 311,5 k € | +40.6% | 221,5 k € | -5.1% | 233,3 k € | +45.5% | 160,4 k € | +86.8% | 85,8 k € | -5.8% | 91,1 k € | +15.8% | 78,7 k € | -58.6% | 190,1 k € | +4.6% | 181,8 k € | |
| Profit/loss | 317,3 k € | +44.6% | 219,5 k € | -12.0% | 249,3 k € | +75.8% | 141,8 k € | +73.3% | 81,8 k € | -55.8% | 185,3 k € | +9.1% | 169,8 k € | +96.0% | 86,7 k € | -53.7% | 187,4 k € | +39.8% | 134,0 k € | -5.9% | 142,3 k € | +5.5% | 134,9 k € | +161.9% | 51,5 k € | +6.1% | 48,5 k € | +8.5% | 44,7 k € | -61.3% | 115,6 k € | -0.7% | 116,4 k € | |
| Equity | 2,0 M € | +18.4% | 1,7 M € | +14.6% | 1,5 M € | +19.9% | 1,3 M € | +12.8% | 1,1 M € | +8.0% | 1,0 M € | +22.0% | 843,3 k € | +25.2% | 673,5 k € | -19.9% | 841,2 k € | +94.9% | 431,5 k € | -3.4% | 446,5 k € | +46.8% | 304,2 k € | +79.7% | 169,3 k € | +43.7% | 117,8 k € | +70.1% | 69,2 k € | -71.7% | 244,5 k € | +89.8% | 128,8 k € | |
| Total assets | 2,2 M € | +6.1% | 2,0 M € | +28.9% | 1,6 M € | +7.5% | 1,5 M € | +3.7% | 1,4 M € | +2.4% | 1,4 M € | +9.3% | 1,3 M € | +13.4% | 1,1 M € | -16.2% | 1,3 M € | +43.8% | 929,3 k € | +65.9% | 560,1 k € | +21.6% | 460,5 k € | +60.5% | 287,0 k € | +3.2% | 278,0 k € | -30.4% | 399,1 k € | -32.1% | 587,8 k € | +44.7% | 406,1 k € | |
| Cash | 153,7 k € | +72.6% | 89,0 k € | +36.1% | 65,4 k € | -48.8% | 127,8 k € | +3.7% | 123,2 k € | -44.5% | 222,1 k € | +263.3% | 61,1 k € | +10.9% | 55,1 k € | -77.3% | 243,2 k € | -57.3% | 570,3 k € | +66.8% | 341,9 k € | +80.3% | 189,6 k € | +228.4% | 57,7 k € | +3436.6% | 1,6 k € | +1.5% | 1,6 k € | -99.1% | 182,6 k € | +158.7% | 70,6 k € | |
| Debts | 128,6 k € | -60.0% | 321,3 k € | +284.7% | 83,5 k € | -62.3% | 221,3 k € | -20.9% | 279,8 k € | -22.1% | 359,2 k € | -15.8% | 426,7 k € | -4.4% | 446,5 k € | -9.8% | 494,9 k € | -0.2% | 495,9 k € | +344.4% | 111,6 k € | -28.0% | 154,9 k € | +32.2% | 117,2 k € | -26.0% | 158,5 k € | -51.8% | 328,4 k € | -3.2% | 339,4 k € | +23.0% | 275,9 k € | |
Private limited company · Roeselare · incorporated on 19/04/2005
Private limited company profitable and well capitalised. Cash position rising (+72.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure. The abridged model hides revenue.
Dr. MARC VANDEVOORT is a Private limited company incorporated in 2005. Its main activity is: Specialist medical practice activities. Its registered office is in Roeselare.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette